Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Vincent Massard
Institut de Cancérologie de Lorraine
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
23
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database
Number of pages: 25
Posted: 19 Apr 2026
William Jacot
,
Pauline MACOUILLARD
,
Suyuan Zhang
,
Danalyn Byng
,
Shannon Hunter
, Vincent Massard,
Jean Sebastien Frenel
,
David Pérol
,
Etienne Brain
,
Audrey mailliez
,
Thomas Bachelot
,
Monica Arnedos
,
Lise Bosquer
and
Véronique Dieras
University of Montpellier, UNICANCER,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Institut de Cancérologie de Lorraine, Institut de Cancérologie de l’Ouest Pays de Loire, University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, Institut Curie - Department of Medical Oncology, CHU Lille - Centre Oscar Lambret, University of Claude Bernard Lyon 1 - Medical Oncology Department, Bergonié Institute, UNICANCER and Centre Eugene Marquis
Downloads
23
(1,448,301)
View PDF
Download
Abstract:
metastatic breast cancer, Real-world evidence, HER2-low, HR-positive, trastuzumab deruxtecan
Feedback